Beneficial effects of alpha 2-adrenoceptor activity on ischemic myocardium during coronary hypoperfusion in dogs.
- 1 December 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 65 (6) , 1632-1645
- https://doi.org/10.1161/01.res.65.6.1632
Abstract
We have previously reported that alpha 2-adrenoceptor stimulation enhances adenosine-induced coronary vasodilation. In the present study, we tested the hypothesis that alpha 2-adrenoceptor activity exerts beneficial effects on myocardial ischemia through augmentation of vasodilatory effects of released adenosine. In open-chest dogs, the left anterior descending coronary artery was perfused through an extracorporeal bypass tube from the carotid artery. Propranolol was infused into the bypass tube to exclude the metabolic effects of norepinephrine. When clonidine (0.24 micrograms/kg/min i.c.) was infused for 10 minutes after reduction of coronary blood flow by partial occlusion of the bypass tube, coronary blood flow was increased by 43% from 27 +/- 1 ml/100 g/min despite no changes in coronary perfusion pressure (38 +/- 5 mm Hg) and a slight decrease in adenosine release. Both fractional shortening and lactate extraction ratio of the perfused area were significantly improved (fractional shortening, 1.8 +/- 1.0 to 10.9 +/- 1.5%, p less than 0.001; lactate extraction ratio, -57.8 +/- 6.5 to -31.9 +/- 2.4%, p less than 0.005). Identical results were observed in the denervated hearts, indicating that the beneficial effect of clonidine is not attributed to the prevention of norepinephrine release from the sympathetic nerve terminals. The beneficial effects of clonidine were prevented by yohimbine, an alpha 2-adrenoceptor blocking agent. An adenosine receptor antagonist, 8-phenyltheophylline, also prevented the beneficial effects of clonidine, indicating that these beneficial effects are mediated by effects of adenosine. Furthermore, the extent of augmentation of coronary flow in the ischemic heart was coincided with that of augmentation of exogenous adenosine-induced hyperemic flow (40%) by clonidine. Production of cyclic AMP in the coronary artery during myocardial ischemia was augmented by clonidine. In 12 other dogs, myocardial ischemia was produced by intracoronary embolization of microspheres (15 microns in diameter). Clonidine enhanced (39%) the hyperemic coronary flow and improved both fractional shortening and lactate extraction ratio. Thus, we conclude that alpha 2-adrenoceptor stimulation can ameliorate myocardial ischemia mainly due to enhancement of vasodilatory effects of adenosine released from the ischemic myocardium.This publication has 36 references indexed in Scilit:
- Molecular characterization of adrenergic receptors.Circulation Research, 1985
- α1 and α2-Adrenoceptor-Mediated Vasoconstriction of Large and Small Canine Coronary Arteries In VivoJournal of Cardiovascular Pharmacology, 1984
- Alpha-adrenergic regulation of the coronary circulation in the conscious dogThe American Journal of Cardiology, 1983
- Norepinephrine constricts the canine coronary bed via postsynaptic α2-adrenoceptorsEuropean Journal of Pharmacology, 1982
- A sensitive radioimmunoassay for adenosine in biological samplesAnalytical Biochemistry, 1982
- An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissueBiochemical Medicine, 1977
- THE ROLE OF H1 AND H2‐RECEPTORS IN THE CORONARY VASCULAR RESPONSE TO HISTAMINE OF ISOLATED PERFUSED HEARTS OF GUINEA‐PIGS AND RABBITSBritish Journal of Pharmacology, 1975
- Succinyl derivatives of adenosine 3′,5′-cyclic monophosphate: Synthesis and purificationAnalytical Biochemistry, 1972
- Adrenal Tyrosine Hydroxylase: Compensatory Increase in Activity after Chemical SympathectomyScience, 1969